Dr Chris Morgan is a physician working in international public health with special interests in global immunisation, health system strengthening, primary health care, international child health, maternal and newborn care, birth-dose vaccination against hepatitis B, and health-worker education and training.
Chris worked at Burnet from 2001-2020 before taking up a role with Jhpiego, the Johns Hopkins University affiliate, leading their immunisation work in Africa and Asia.
Prior to commencing at Burnet, Chris worked in primary health care in Tibet, China (1997-2000), in community health and hospital paediatrics in Nepal (1993-7), having trained as a paediatrician at the Royal Alexandra Hospital for Children in Sydney (now Children's Hospital Westmead) from 1984-1992. During that time he undertook additional work in indigenous child health, tropical paediatric specialisation, and developing a child health training program for primary care physicians.
Chris completed his doctoral degree at the University of Melbourne's Department of Medicine, researching the integration of other services with immunisation, including studies embedded in Burnet's Healthy Mothers Healthy Babies program in PNG.
Chris has coordinated the MPH subject Primary Health Care in Developing Countries from 2003–2013, and continues to support post-graduate education, including coordination of the Postgraduate Diploma in Tropical Medicine and Hygiene commencing in 2014.
PLOS Global Public Health
Yasmin I. Mohamed, Rachael Farquhar, Chris Morgan, Annie Dori, Samuel McEwen, Leanne J. Robinson, Annie Dori, Rachael Farquhar, Yasmin I. Mohamed, Chris Morgan
PLOS Global Public Health
Yasmin I. Mohamed, Rachael Farquhar, Chris Morgan, Annie Dori, Samuel McEwen, Leanne J. Robinson, Annie Dori, Rachael Farquhar, Yasmin I. Mohamed, Chris Morgan
PLOS Global Public Health
Yasmin I. Mohamed, Rachael Farquhar, Chris Morgan, Annie Dori, Samuel McEwen, Leanne J. Robinson, Annie Dori, Rachael Farquhar, Yasmin I. Mohamed, Chris Morgan
This project compares the performance of novel high sensitivity Plasmodium falciparum rapid diagnostic tests with conventional tests.
Implemented in partnership with the Tibet Regional Health and Family Planning Commission, this is the latest in a decade-long relationship between agencies, funded by the Australian government, working together to strengthen the Tibet Autonomous Region (TAR) health system.
Burnet, in partnership with local and international researchers, led the impact evaluation of this project to document successes and guide future UN investments.